newsfilter
← Latest News
GlobeNewswire·

RVL Pharmaceuticals plc to Discuss Second Quarter 2022 Financial Results and Provide Commercial Update

BRIDGEWATER, N.J., Aug. 04, 2022 (GLOBE NEWSWIRE) -- RVL Pharmaceuticals plc (NASDAQ:RVLP) ("RVL" or the "Company"), a specialty pharmaceutical company focused on the commercialization of UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1%